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IMPORTANCE There is concern about potentially causal effects of tobacco use on psychosis,
but epidemiological studies have been less robust in attempts to minimize effects of
confounding than studies of cannabis use have been.
OBJECTIVES To examine the association of patterns of cigarette and cannabis use with
preceding and subsequent psychotic experiences, and to compare effects of confounding
across these patterns.
DESIGN, SETTING, AND PARTICIPANTS This cohort study used data from the Avon Longitudinal
Study of Parents and Children, which initially consisted of 14 062 children. Data were
collected periodically from September 6, 1990, with collection ongoing, and analyzed from
August 8, 2016, through June 14, 2017. Cigarette and cannabis use data were summarized
using longitudinal latent class analysis to identify longitudinal classes of substance use.
Associations between classes and psychotic experiences at age 18 years were assessed.
EXPOSURES Depending on the analysis model, exposures were longitudinal classes of
substance use or psychotic experiences at age 12 years.
MAIN OUTCOMES ANDMEASURES Logistic regressionwas used to examine the associations
between substance use longitudinal classes and subsequent onset of psychotic experiences.
RESULTS Longitudinal classes were derived using 5300 participants (56.1% female) who had
at least 3 measures of cigarette and cannabis use from ages 14 to 19 years. Prior to adjusting
for a range of potential confounders, there was strong evidence that early-onset
cigarette-only use (4.3%), early-onset cannabis use (3.2%), and late-onset cannabis use
(11.9%) (but not later-onset cigarette-only use [14.8%]) latent classes were associated with
increased psychotic experiences compared with nonusers (65.9%) (omnibus P < .001). After
adjusting for confounders, the association for early-onset cigarette-only use attenuated
substantially (unadjusted odds ratio [OR], 3.03; 95% CI, 1.13-8.14; adjusted OR, 1.78; 95% CI,
0.54-5.88), whereas those for early-onset cannabis use (adjusted OR, 3.70; 95% CI,
1.66-8.25) and late-onset cannabis use (adjusted OR, 2.97; 95% CI, 1.63-5.40) remained
consistent.
CONCLUSIONS AND RELEVANCE In this study, our findings indicate that while individuals who
use cannabis or cigarettes during adolescence have an increased risk of subsequent psychotic
experiences, epidemiological evidence is substantively more robust for cannabis use than it is
for tobacco use.
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C annabis and tobaccoare frequentlyused together, iden-tifying their individual associations on mental healthis difficult but important, as this can advance under-
standing of causal mechanisms and help target preventive
interventions.
Individualswhouse cannabis regularly have a 2- to 3-fold
increased risk of a psychotic outcome.1 Tobaccouse is also as-
sociatedwith an increased incidenceof psychotic disorders2-5
in cohort studies, and (less consistently)with subclinical psy-
chotic symptoms,6-8withhypothesizedcasualmechanisms in-
cludingnicotine increasingdopamine releaseand inducingD2-
receptor supersensitivity.5,9
However,whilearecentsystematic reviewreportedameta-
analysisestimate fordailysmokingandpsychosis thatwassimi-
lar to that for regular cannabis use, the estimate was based on
results unadjusted for confounders,5 unlike that for cannabis.1
While concernabout confounding leading tooverestimationof
association on psychosis also exists for cannabis,1 support for
causal effects of cannabis also comes fromexperimental stud-
ies showing an increase inpsychotic experiences following ex-
posureto intravenousΔ9-tetrahydrocannabinol (THC).10 Incon-
trast, experimental studies of nicotine administration do not
support the acute onset of psychotic experiences.11
The strongest evidence of a causal effect of tobacco on
psychosis is that a genetic locus associated with heaviness
of smoking (within the nicotinic receptor CHRNA5-A3-B4
gene cluster) is 1 of the loci most strongly associated with
schizophrenia.12 However, this is also theoretically consistent
with either confounding by shared genetic effects (biological
pleiotropy)or, perhaps lessplausibly, reverse causality (ie, bio-
logical risk of schizophrenia causing smoking behavior).
Associations between genetic risk for psychosis and both
cannabis use and heaviness of cigarette use are also consis-
tent with causal effects, reverse-causal effects, and pleiot-
ropy explanations.13-15
As most people who use cannabis also smoke cigarettes,
teasing out potentially causal effects of cannabis from those
of tobacco is difficult, particularly as individuals usually mix
their cannabis with tobacco, even when classing themselves
as nonsmokers.16Measurement error can lead to incorrect es-
timates of causal effects (see Gage et al16 and Munafò et al17
forexamplesof the impactofmeasurementerroronconfound-
ing and main effects) and is particularly likely when using
single–timepoint assessments of exposure status. Thus, other
methods for teasing out causal effects of cannabis as distinct
from tobacco are required.
One approach that can help inform causal inference is to
usebehavioralpatternsof cannabis andcigaretteuseover time
to identify classes of individualswith different substance use
profiles across a developmental period rather than relying on
patternsofcannabisandcigaretteuseatasinglepoint in time.18
Such methods capture additional information that may en-
able continual users of cannabis and cigarettes to be distin-
guished from those whomay have experimented briefly.
In this study, we used longitudinal latent class analysis
(LLCA) to identify subgroups of individuals based on similar
patterns of cigarette and cannabis use behavior over time to
examine the association of different classes with subsequent
onsetofpsychoticexperiences, comparepatternsof confound-
ing across these classes, and examine the associationof child-
hood psychotic experienceswith adolescent patterns of ciga-
rette and cannabis use.
Methods
Participants
The sample comprised individuals within the Avon Longitu-
dinal Study of Parents and Children birth cohort. The initial
cohort consistedof 14062 childrenborn towomen residing in
the former Avon Health Authority area with expected deliv-
ery dates fromApril 1, 1991, toDecember 31, 1992.19-21 All par-
ticipants provided written informed consent, and ethical ap-
proval was obtained from the Avon Longitudinal Study of
Parents and Children Ethics and Law Committee and the
local research ethics committees.
Measures
Cigarette and Cannabis Use
Measuresof cigaretteandcannabisusewerecollectedat6 time
points betweenages 14 and 19years (eAppendix in the Supple-
ment).Asvery fewindividualsusedcannabiswithout tobacco16
(eTable 1 in theSupplement),dataateach timepointweresum-
marized as individualswhodid not report cigarettes or canna-
bis use, individuals who reported cigarette use only, and indi-
vidualswhoreportedcannabisuse (withorwithoutcigarettes).
Psychotic Experiences
The semi-structured psychosis-like symptom interview
(PLIKSi)22,23 was used to assess psychotic experiences at ages
12 and 18 years. The PLIKSi allows rating of 12 psychotic ex-
periences including hallucinations, delusions, and thought
interference.
Theprimarypsychotic experiencemeasures at ages 12 and
18yearswerebinaryvariables relating towhetheran individual
hadat least 1definitepsychotic experiencecomparedwith sus-
pectedornopsychotic experiences.As sensitivity analyses,we
also repeatedanalysesusingnarrower (definitepsychoticexpe-
riencesvsnone;psychoticdisordervsnone) andbroader (defi-
Key Points
Question Are patterns of adolescent cigarette and cannabis use
differentially associated with subsequent onset of psychotic
experiences?
Findings In this longitudinal cohort study of 3328 adolescents,
there is evidence that both cannabis and cigarette use are
associated with subsequent psychotic experiences prior to
adjusting for confounders. However, after adjusting, the
associations for cigarette-only use attenuated substantially,
whereas those for cannabis use remained consistent.
Meaning While individuals who use either cannabis or cigarettes
during adolescence appear to be at increased risk of psychotic
experiences, the association of psychotic experiences is greater
with cannabis than with tobacco smoking.
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niteor suspectedpsychoticexperiencesvsnone) cutoffs forde-
fining the outcome (eAppendix in the Supplement).
Potential Confounders
Potential confounders examined included sex, family history
of schizophreniaordepression, familyhistoryofdruguse,ma-
ternal and/or paternal smoking during pregnancy, maternal
education,highestparental social class, IQ (age8years), child-
hood trauma or experiencing bullying (ages 7-9 years), emo-
tional and behavioral problems (Strengths and Difficulties
Questionnaire score, age9years), andalcoholuse (age 12years)
(eAppendix in the Supplement).
Statistical Analysis
Longitudinal Latent Class Analysis
Longitudinal latentclassanalysiswasusedtoderivedistinctbe-
havior patterns in the repeated-measures data relating to ciga-
rette and/or cannabisuseaspreviouslydescribed.24,25Theaim
ofLLCAistoidentifythenumberof latentclassesthatadequately
explain the relationship between the observed variables. Indi-
vidualswere included intheanalysis if theyhaddatapresent for
3ormoretimepoints.Startingwith1class,additionalclasseswere
addedandthemodel fitwasassesseduntil theoptimalnumber
ofclasseswasachieved.Model fitwasassessedusingthefollow-
ingparameters: proportionof individuals ineachclass, sample
size–adjustedBayesian informationcriterion, andLo-Mendell-
Rubin likelihoodratiotest.Longitudinal latentclassanalysiswas
performed usingMPlus version 7.31 software.26
Association Analyses
Psychotic Experiences as Exposure |Multinomial regression was
used to assess whether psychotic experiences at age 12 years
wereassociatedwith subsequent latent classmembership, be-
fore and after adjustment for potential confounders, using a
manual implementation of the bias-adjusted 3-step method
(eAppendix in the Supplement).27 Analyses were also con-
ducted on a restricted sample omitting 455 participants who
used cannabis or cigarettes at age 12 years.
Psychotic Experiences as Outcome |Logistic regressionwas used
toassesswhether latent classmembershipwasassociatedwith
subsequent psychotic experiences at age 18 years, before and
after adjustment for potential confounders. For these analy-
ses, derivation of classes was restricted to data from the first
to fourth time point (approximate ages 14-17 years). Other-
wise, themethodused to derive classeswas as previously de-
scribed. Restricting data to 4 time points hadminimal impact
on latent class structure and proportions (eFigure and eTable
2 in the Supplement). Analyses were also conducted on a re-
stricted sample omitting 149 participants with definite psy-
chotic experiences at age 12 years.
Adjusting for family history of schizophrenia or depres-
sion, familyhistoryofdruguse,paternal smokingduringpreg-
nancy, social class, IQ, experiencing bullying, childhood
trauma, and alcohol use had almost no association with re-
sults for either model previously described (eTable 3 in the
Supplement) but reduced the analysis sample size substan-
tially. We therefore only adjusted for sex, maternal educa-
tion,maternal smokingduringpregnancy, andchild Strengths
andDifficultiesQuestionnairescore inour finaladjustedmodel.
Missing Data
Percentageofmissingdata increasedwith time (eTable4 in the
Supplement). Participants in the analysis sample were more
likely to be female and to come frommore advantaged back-
grounds (Table 1 and eTable 5 in the Supplement).
Results
Datawereavailable for5300participants (56.1%female).Based
onmodel fit statistics (eTable 6 in the Supplement), therewas
good agreement that a 5-class solution adequately described
the heterogeneity within the data.
The 5-class model comprised individuals with a higher
probability of early-onset cigarette-only use (4.3%), early-
onset cannabis use (3.2%), late-onset cigarette-only use
(14.8%), late-onset cannabis use (11.9%), and individualswith
a very low probability of cigarette or cannabis use (65.9%; re-
ferred to as nonusers) (Figure).
Patterns of Cigarette and/or Cannabis Use at Ages
14 to 17 Years and Psychotic Experiences at Age 18 Years
Individualswithin theearly-onset cigarette-only class, butnot
the late-onset cigarette-only class, had greater odds of psy-
chotic experiences at age 18 years when compared with non-
users (odds ratio [OR], 3.03; 95% CI, 1.13-8.14; and OR, 0.84;
95% CI, 0.31-2.31, respectively) (Table 2).
There was strong evidence that participants within the
early-onset and late-onset cannabis use classes also had in-
creased odds of psychotic experiences (early-onset cannabis
Table 1. Sample Demographics for ParticipantsWho Completed Questions Related to Cigarette and Cannabis
Use per Time Pointa
Time
Point Data Source
Respondents/
Time Point, No.
Female,
No. (%)
Age, y
Mean Median (Range)
1 Interview 4654 2530 (54.4) 13.8 13.8 (12.5-15.2)
2 Postal questionnaire 4537 2608 (57.5) 14.2 14.1 (14-16.2)
3 Interview 4421 2421 (54.8) 15.4 15.3 (14.3-17.5)
4 Postal questionnaire 4169 2478 (59.4) 16.7 16.6 (16.4-18.1)
5 Interview 3541 2002 (56.5) 17.7 17.7 (16.3-19.6)
6 Postal questionnaire 2927 1878 (64.2) 18.6 18.7 (17.8-20)
a Approximate age used to plot the
data was 14 years for time point 1,
15 years for time point 2, 16 years for
time point 3, 17 years for time point
4, 18 years for time point 5, and 19
years for time point 6.
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use: OR, 3.79; 95% CI, 1.73-8.31; late-onset cannabis use:
OR,3.05; 95% CI, 1.69-5.53).
Whenadjusting for confounding, the evidenceof associa-
tionbetweenearly-onset cigarette-onlyuse andpsychotic ex-
perienceswasattenuatedbyapproximately60%(adjustedOR,
1.78; 95% CI, 0.54-5.88) (Table 3). In contrast, adjusting for
confounding had minimal impact on the associations for
early-onset cannabis use (adjusted OR, 3.70; 95% CI, 1.66-
Table 2. Associations Between Cigarette and/or Cannabis Use and Psychotic Experiences at Age 18 Years
Variable
Definite Psychotic Experiences
(n = 3328)
Unadjusted Adjusted
OR (95% CI)a P Valueb OR (95% CI)a,c P Valueb
Early-onset <.001 <.001
Cigarette-only 3.03 (1.13-8.14) 1.78 (0.54-5.88)
Cannabis 3.79 (1.73-8.31) 3.70 (1.66-8.25)
Late-onset
Cigarette-only 0.84 (0.31-2.31) 0.73 (0.27-1.98)
Cannabis 3.05 (1.69-5.53) 2.97 (1.63-5.40)
Abbreviation: OR, odds ratio.
a Compared with nonusers class.
b The omnibus P value for
associations between cigarette
and/or cannabis use classes and
psychotic experiences at age 18
years.
c Adjusted for sex, maternal
education, emotional and
behavioral problems (Strengths and
Difficulties Questionnaire score at
age 9 years), andmaternal cigarette
smoking during pregnancy.
Table 3. Associations Between Psychotic Experiences at Age 12 Years and Subsequent Cigarette and/or Cannabis Use
Definite PE
OR (95% CI)a
P Valueb
Early-Onset Late-Onset
Cigarette Cannabis Cigarette Cannabis
Unadjusted (n = 4101) 1.17 (0.41-3.33) 0.97 (0.31-3.00) 1.76 (1.01-3.10) 1.66 (0.94-2.91) .14
Adjusted (n = 4101)c 0.86 (0.27-2.81) 0.93 (0.28-3.06) 1.60 (0.91-2.82) 1.65 (0.90-3.05) .25
Abbreviations: OR, odds ratio; PE, psychotic experiences.
a Compared with nonusers class.
b The omnibus P value for association between psychotic experiences at age
12 years and cigarette and/or cannabis use classes.
c Adjusted for sex, maternal education, emotional and behavioral problems
(Strengths and Difficulties Questionnaire score at age 9 years), andmaternal
cigarette smoking during pregnancy.
Figure. Five-ClassModel of Cigarette and Cannabis Use Patterns From a Sample of 5300 Participants
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8.25) or late-onset cannabis use (adjusted OR, 2.97; 95% CI,
1.63-5.40).
Whencomparing thesubstanceuseclasseswitheachother
(eTable 7 in the Supplement), therewas strongevidence to rule
outequivalencebetweentheassociationof late-onset cannabis
useandlate-onsetcigarette-onlyusewithpsychoticexperiences
(OR,3.63;95%CI, 1.12-11.76).Therewas insufficientevidence to
supportadifferencebetweentheassociationofearly-onsetcan-
nabis andearly-onset cigarette-onlyusewithpsychotic experi-
ences,althoughthiswasbasedonsmallernumbers,ortosupport
a difference between late-onset and early-onset cannabis use
classes.Resultsweresimilarwhenexcludingindividualswithpsy-
chotic experiences at age 12years (eTable 7 in theSupplement).
Sensitivity Analyses
Results of associations between class membership and sub-
sequent psychotic experiences were substantively the same
whenexcludingparticipantswhosepsychoticexperiencesonly
ever occurred within 2 hours of any drug use (eTable 8 in the
Supplement) and when examining narrower or broader psy-
chotic outcome definitions (eTable 9 in the Supplement).
Psychotic Experiences at Age 12 Years and Patterns
of Cigarette and/or Cannabis Use at Ages 14 to 19 Years
Definite psychotic experiences at age 12 years were associ-
ated with increased odds of subsequent late-onset cigarette-
only use (OR, 1.76; 95% CI, 1.01-3.10) and late-onset cannabis
use (OR, 1.66; 95% CI, 0.94-2.91) as compared with nonusers
(Table 3 and eTable 10 in the Supplement).
Therewas little evidence thatpsychotic experiences at age
12 years were associated with increased odds of early-onset
cigarette-onlyorcannabisuse;however,theseclasseshadsmaller
membership(FigureandTable3).Adjustingforconfoundershad
minimal impactonassociationsbetweenpsychoticexperiences
at age 12 years and classes of subsequent cannabis and/or ciga-
rette use. The effect estimates for all classeswere smaller, and
evidence of association weaker (particularly for early-onset
classes),when restricting theanalysis tononusersof cigarettes
and/or cannabis at age 12 years (eTable 11 in the Supplement).
Discussion
Both early-onset and late-onset cannabis use classeswere as-
sociated with psychotic experiences at age 18 years and were
only minimally attenuated after adjusting for potential con-
founders. In contrast, there was inadequate evidence to sup-
port an association between either early-onset or late-onset
cigarette-only use and psychotic experiences in the adjusted
analyses. Therewasalso evidence thatparticipants in the late-
onset cannabis use class had higher odds of psychotic expe-
riences than those in the late-onset cigarette-only use class,
the 2 most common substance use classes in our data. There
was no evidence to support a stronger association of early-
onset cannabis use comparedwith late-onset cannabis use on
psychotic outcomesasproposedby some,butnot all, studies,1
although the relatively small size of the early-onset class has
limited power to detect small-moderate effects.
Adjusting for a broad range of potential confounders did
not alter theestimateof association for either theearly- or late-
onset cannabisuse classbut resulted inanapproximately60%
attenuation of the estimate for the early-onset cigarette-only
class. This difference in the impact of adjustment for con-
founders indicates that the association between cannabis use
and psychotic experiences is more robust against explana-
tions of residual confounding than that for tobacco use.
In comparison,we found little evidence that psychotic ex-
periences in childhood led to increased cannabis use. As other
observational studies have indicated,28-30 the self-medication
hypothesis does not appear to adequately explain the associa-
tion between cannabis use and psychosis. Such a relationship
for tobacco use is also not well supported by our data.
Theuncertaintyaroundourestimatesmeanswecannotex-
clude a possible association of cigarette-only use with psy-
chotic experiences. A number of longitudinal studies have re-
ported that tobacco users are at greater risk for later psychotic
disorders.2-5,31,32 However, none of these studies adjusted for
cannabis use, andwhile adjusting for diagnoses of drug abuse
in2of thestudiessubstantiallyattenuatedassociations forciga-
rettesmoking4orsnususe,32 this is likelyapoormeasureofcan-
nabis use and hence may have underestimated its confound-
ingeffect. In theonly longitudinal study, toourknowledge, that
hasadjusted for cannabisuse, this substantially attenuated the
association forcigarettesmoking,with the fullyadjustedmodel
supporting a protective effect of smoking on schizophrenia.33
In our previous study using the Avon Longitudinal Study
of Parents and Children cohort, we reported that the associa-
tion between cannabis use and psychotic experienceswas al-
tered only slightly by adjusting for early or childhood con-
foundersbut that interpretationof results adjusted for tobacco
use was problematic because of a strong relationship be-
tweenthesemeasures.16 In thecurrent study,wearebetterable
todisentangle differential effects of tobaccouse from thoseof
cannabisuse throughuseofdata atmultiple timepoints tode-
scribe patterns of use associated with both of these sub-
stances over time. Our findings are consistent with another
study in which adjusting for confounding using fixed-effects
regression todealwithunmeasured time-invariant effects re-
sulted inmuchgreaterattenuationofassociationbetweenciga-
rette smokingandpsychotic symptoms than for cannabisuse.8
Anotherapproachtostrengthencausal inference ismende-
lianrandomizationwherebygeneticvariantsactasassumedun-
confoundedproxymeasuresforexposurestatus.34Onestudyre-
portedweakevidenceof associationbetweenagenetic variant
withintheCHRNA5-A3-B4geneclusterandbeingprescribedan-
tipsychoticmedication.35However,despitethisassociationbeing
stronger in smokers thannonsmokers (aswouldbe expected if
thiswasduetoacausal roleof smokingonpsychosis), therewas
little statistical evidence for this (P = .60).35
We recently conducted amendelian randomization study
and found little association between cigarette smoking initia-
tion and schizophrenia risk,36 while our mendelian random-
ization study of cannabis initiation and schizophrenia risk
provided evidence for causal pathways operating in both
directions.14 However, in both cases our analyses were
restricted to smoking and cannabis initiation and might not
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reflect the effects of longer-term regular use. The lack of ad-
equate samples and strong genetic instruments for regular
cannabis use limit current use of mendelian randomization
studies to further inform causal inference.
Limitations
One of the strengths of our study is that we use a large, well-
characterized cohort, albeit ofmostly European ancestry, with
multiplemeasuresofexposuresof interest andpsychoticexpe-
riencedataovertime,withdataonabroadrangeofpotentialcon-
founders collected prospectively. Using information across the
entire adolescent period rather than from a single time point
means our results are much less prone to measurement error.
However, there is considerableattritionover time,althoughthe
use of a latent classmethodwith longitudinal data allows us to
maximizeuseofdataforindividualsevenwhereparticipationand
questionresponsehavebeensporadic,andhencetominimizepo-
tential selection bias to some extent.While use of a latent class
methodconfersanumberofadvantagesoverusingmeasuresat
singletimepoints, itwasnotpossibletodefineaclassof individu-
als who use cannabis without tobacco as most cannabis users
smoke cannabis in combination with tobacco.37 Therefore, we
cannot ruleoutwhether theassociationsobservedbetweenthe
cannabisuseclassandpsychoticexperiencesareexacerbatedby
thecombineduseofcannabisandcigarettes.Whileexperimen-
tal studiesof intravenousΔ9-THCsupportacausaleffectofcan-
nabisonacutepsychoticexperiences intheabsenceoftobacco,10
there is someevidence that smokingcannabiswith tobaccoalso
increases the amount of THC inhaled per gram.38
Furthermore, we have previously found that a substan-
tial proportion of people who smoke cigarettes most heavily
also use cannabis, and thus the cigarette-only classmight not
include those who have been most heavily exposed to to-
bacco. As the cannabis use group in our study included occa-
sional (1-3 times in thepast 6months) and frequent (daily) us-
ers, we were unable to differentiate whether our findings are
mainly driven by frequent users; including frequency of sub-
stance use data resulted in an unstablemodel. Our studywas
also not able to examine associations of longer-term cumula-
tive cannabis and tobacco use and psychosis outcomes, al-
though these analyses may become tractable in the future.
While psychotic experiences in the population are rela-
tively poor predictors of psychotic disorder,23 they represent
the key characteristic of such disorders, and understanding
their etiology almost certainly has relevance to understand-
ing the etiology of clinically defined psychosis. However, we
werenot adequatelypowered to investigate the effects of can-
nabis or cigarette use on psychotic disorders and cannot rule
out different effects of these substances on other psychosis-
relatedpsychopathology, suchasnegative symptoms.Wewere
also unable to tease out associations of cannabiswith chronic
vs acute psychotic outcomes, although excluding individuals
whoreportedpsychoticexperiencesonlyeveroccurringwithin
2hours of usingdrugs hadminimal effect onour results. Nev-
ertheless, given the long half-life of THC, the only way of de-
termining whether cannabis use can lead to chronic psy-
chotic disorders that persist long after potential effects of
exogenous cannabinoids is to study regular users of cannabis
who subsequently become abstinent.30
Theone longitudinal studyofwhichweare aware that ex-
amined this relationship reported only weak evidence of as-
sociation between ex–cannabis use and psychotic experi-
ences, although therewere relatively fewex–cannabisusers.30
Given the age of the participants over the course of our study,
we were not able to identify a class of ex–cannabis users to
clarify this relationship; however, long-term follow-upof this
cohort may enable us to address this questionmore robustly.
Conclusions
Our study found that both adolescent cannabis use and ciga-
retteuseareassociatedwith increased risk for subsequentpsy-
chotic experiences. This association was greater for canna-
bis.Associationsobservedbetween tobaccouseandpsychotic
experiences aremore likely than those for cannabis use to be
influencedbyother characteristicsofpeoplewhodeveloppsy-
chotic experiences.
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